AT-527

Atea’s antiviral pill fails to clear Covid-19, forcing a re-think
Stat
Tue, 10/19/21 - 10:48 am
Atea Pharmaceuticals
COVID-19
antivirals
clinical trials
Roche
AT-527
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
Motley Fool
Fri, 10/8/21 - 10:58 am
COVID-19
Merck
Ridgeback Therapeutics
Roche
Atea Pharmaceuticals
AT-527
antivirals
Roche joins the COVID-19 antiviral drug race, betting $350M on a startup
BioPharma Dive
Thu, 10/22/20 - 10:51 am
Roche
antivirals
Atea Pharmaceuticals
COVID-19
AT-527
Atea raises $215M to support midphase COVID-19 antiviral trial
Fierce Biotech
Wed, 05/20/20 - 10:30 am
Atea Pharmaceuticals
clinical trials
COVID-19
antivirals
AT-527